THOMAS BALES: Open Payments
NPI 1649766114 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$10,373 in 14 payments from 9 companies in 2025. Trend: 2023 $3,515 · 2024 $1,380 · 2025 $10,373
Consulting: $10,000Food & beverage: $373
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 2 | $10,116 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $84 |
| ABBVIE INC. | 3 | $52 |
| Janssen Pharmaceuticals, Inc | 1 | $27 |
| Alkermes, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $21 |
| Bausch Health US, LLC | 1 | $19 |
| Indivior Inc. | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
Products named: SPRAVATO, CAPLYTA, VRAYLAR, ARISTADA, REXULTI, APLENZIN, SUBLOCADE, Jornay PM.
Industry payments across RI — which companies pay providers there.
